Quinapril

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 860 publications

Environmental sustainability assessment of reverse-phase liquid chromatography for retention and ionization profiling of angiotensin-converting enzyme inhibitors.

Environmental sustainability assessment of reverse-phase liquid chromatography for retention and ionization profiling of angiotensin-converting enzyme inhibitors.

Journal: Journal of pharmaceutical and biomedical analysis

Published: January 20, 2026

Peripheral endothelial and coronary microvascular responses to lipophilic versus hydrophilic ACE inhibitors in newly diagnosed hypertension.

Peripheral endothelial and coronary microvascular responses to lipophilic versus hydrophilic ACE inhibitors in newly diagnosed hypertension.

Journal: Journal of hypertension

Published: January 17, 2026

Adverse event of ACE inhibitors: A descriptive analysis of FAERS data.

Adverse event of ACE inhibitors: A descriptive analysis of FAERS data.

Journal: Journal of public health research

Published: October 25, 2025

Eight-year outcomes from the WHiTE3 HEMI trial : comparing the Thompson hemiarthroplasty with the Exeter polished tapered stem and Unitrax modular head in the treatment of displaced intracapsular hip fractures at a single centre.

Eight-year outcomes from the WHiTE3 HEMI trial : comparing the Thompson hemiarthroplasty with the Exeter polished tapered stem and Unitrax modular head in the treatment of displaced intracapsular hip fractures at a single centre.

Journal: Bone & joint open

Published: October 20, 2025

Comparison chart: Some drugs for HFrEF.

Comparison chart: Some drugs for HFrEF.

Journal: The Medical letter on drugs and therapeutics

Published: May 19, 2025

Drugs for chronic heart failure.

Drugs for chronic heart failure.

Journal: The Medical letter on drugs and therapeutics

Published: May 19, 2025

Molecular basis of domain-specific angiotensin I-converting enzyme inhibition by the antihypertensive drugs enalaprilat, ramiprilat, trandolaprilat, quinaprilat and perindoprilat.

Molecular basis of domain-specific angiotensin I-converting enzyme inhibition by the antihypertensive drugs enalaprilat, ramiprilat, trandolaprilat, quinaprilat and perindoprilat.

Journal: The FEBS journal

Published: March 20, 2025

Safety of Drugs in Breastfeeding Women With CKD.

Safety of Drugs in Breastfeeding Women With CKD.

Journal: Kidney international reports

Published: March 06, 2025

Amlodipine-Associated Angioedema: An Integrated Pharmacovigilance Assessment Using Disproportionality and Interaction Analysis and Case Reviews.

Amlodipine-Associated Angioedema: An Integrated Pharmacovigilance Assessment Using Disproportionality and Interaction Analysis and Case Reviews.

Journal: Journal of clinical medicine

Published: January 09, 2025

Repurposed drugs as PCSK9-LDLR disruptors for lipid lowering and cardiovascular disease therapeutics.

Repurposed drugs as PCSK9-LDLR disruptors for lipid lowering and cardiovascular disease therapeutics.

Journal: Molecular diversity

Published: November 04, 2024

An updated review on therapeutic strategies in coronary microvascular dysfunction.

An updated review on therapeutic strategies in coronary microvascular dysfunction.

Journal: International journal of cardiology

Published: September 02, 2024

Evaluation of the nitrosamine impurities of ACE inhibitors using computational, in vitro, and in vivo methods demonstrate no genotoxic potential.

Evaluation of the nitrosamine impurities of ACE inhibitors using computational, in vitro, and in vivo methods demonstrate no genotoxic potential.

Journal: Environmental and molecular mutagenesis

Published: June 28, 2024

Showing 1-12 of 860

Last Updated: 09/26/2026